دورية أكاديمية

Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma.

التفاصيل البيبلوغرافية
العنوان: Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma.
المؤلفون: Meyer, A. H.1, Stroux, A.2, Lerch, K.1, Eucker, J.3, Eitle, J.4, Hohloch, K.4, Andrzejak, M.1, Possinger, K.3, Dörken, B.1, Pezzutto, A.1, Scholz, C. W.1,5
المصدر: Annals of Oncology. Jan2014, Vol. 25 Issue 1, p210-215. 6p.
مصطلحات موضوعية: *B cell lymphoma, *LYMPHOMAS, *CANCER prognosis, *LACTATE dehydrogenase, *MULTIVARIATE analysis, *FOLLOW-up studies (Medicine)
مستخلص: Marginal zone lymphoma is an indolent lymphoma with a generally favorable prognosis. In a multivariate analysis, however, we identify LDH above upper level of normal, additional malignancy, and transformation as novel risk factors for a diminished OS. Remarkably, patients that demonstrated one or more of the risk factors had an almost 23-fold risk for death (hazard ratio 22.8; P = 0.002) for death.Background Marginal zone lymphoma (MZL) is a non-Hodgkin lymphoma that occurs as extra nodal, nodal, or splenic. While MZL is generally considered an indolent disease, a substantial percentage of patients follow an unfavorable course. The objective of this retrospective analysis was to identify predictors for a reduced overall survival (OS), or conversely an increased OS. Patients and methods One hundred and ninety-seven MZL patients were analyzed. Apart from assessing previously published risk factors, concomitant morbidity at diagnosis, transformation into aggressive lymphoma, and occurrence of additional malignancies were evaluated. Results Next to the known risk factors, i.e. above 60 years of age and elevated serum lactate dehydrogenase (LDH), we demonstrate that transformation into aggressive lymphoma, as well as additional malignancies, are important independent risk factors for a shortened OS in a multivariate analysis, irrespective of the MZL localization. Impressively, in the group of patients lacking LDH elevation, transformation, and/or additional malignancies, only 1 of 63 patients died during follow-up compared with 37 of 87 patients in the high-risk group (HR = 22.8; 95% confidence interval 3.1–167.0; P = 0.002). Conclusions Our analysis proposes novel risk factors and warrants for a continuous follow-up to detect the occurrence of transformation and additional malignancies early on. [ABSTRACT FROM AUTHOR]
قاعدة البيانات: Academic Search Index
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdt507